Liofora Diario

Drospirenone/Ethinylestradiol, the active ingredient in Liofora Diario, is a combined oral contraceptive presented as an oral tablet for systemic use. It is prescribed to prevent pregnancy and to help regulate menstrual cycles in women of reproductive age. The formulation combines a progestogenic steroid with an estrogenic component to provide reliable cycle control and contraceptive efficacy.

GNH USA supplies Liofora Diario as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Liofora Diario, a combined oral contraceptive, is used in the management of reproductive health conditions. - Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. - Menstrual cycle regulation: provides more predictable bleeding patterns and reduces dysmenorrhea. - Acne treatment: improves moderate acne associated with androgen excess in women. - Premenstrual syndrome relief: lessens symptoms such as mood swings and breast tenderness. - Polycystic ovary syndrome symptom management: helps control menstrual irregularities and hyperandrogenic signs.

Liofora Diario may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or soreness of the breasts. - Spotting or breakthrough bleeding: irregular light bleeding between periods.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Stroke or transient ischemic attack: neurological events due to clot formation. - Myocardial infarction: heart attack resulting from coronary artery blockage. - Severe allergic reaction: anaphylaxis, angioedema, or skin rash.

Before prescribing Liofora Diario, clinicians should evaluate several safety considerations to minimise risk. - Assess cardiovascular risk: review history of thromboembolic disorders, hypertension, or smoking. - Evaluate hepatic function: avoid use in severe liver disease. - Counsel about missed tablets: advise prompt action and backup contraception. - Review concomitant medications: consider potential drug interactions that may reduce efficacy. - Avoid use during pregnancy: discontinue if pregnancy is confirmed. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Liofora Diario can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): markedly reduce contraceptive efficacy. - Certain antiretrovirals (e.g., protease inhibitors): may lower hormone levels. - St John’s wort: herbal supplement that accelerates hormone metabolism.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors): drospirenone may increase serum potassium. - Potassium‑sparing diuretics: risk of hyperkalaemia when combined. - Selective serotonin reuptake inhibitors: may affect mood or bleeding patterns.